Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 92 entries
Sorted by: Best Match Show Resources per page
Planning for Briggs-2: nurse allocation.

Nursing times

Harrold AE, Pace AJ.
PMID: 4839417
Nurs Times. 1974 May 30;70(22):suppl:13-6.

No abstract available.

Cite
Harrold AE, Pace AJ. Planning for Briggs-2: nurse allocation. Nurs Times. 1974;70(22):suppl:13-6
Harrold, A. E., & Pace, A. J. (1974). Planning for Briggs-2: nurse allocation. Nursing times, 70(22), suppl:13-6.
Harrold, A E, and Pace, A J. "Planning for Briggs-2: nurse allocation." Nursing times vol. 70,22 (1974): suppl:13-6.
Harrold AE, Pace AJ. Planning for Briggs-2: nurse allocation. Nurs Times. 1974 May 30;70(22):suppl:13-6. PMID: 4839417.
Copy Download .nbib Format: NLM
Early dislocation rate in ceramic-on-ceramic total hip arthroplasty.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery

Mai K, Hardwick ME, Walker RH, Copp SN, Ezzet KA, Colwell CW.
PMID: 18751856
HSS J. 2008 Feb;4(1):10-3. doi: 10.1007/s11420-007-9060-5.

Wear debris from metal-on-polyethylene articulation in conventional total hip arthroplasty (THA) may limit THA longevity. Bearing surfaces made of modern ceramic material, with high wear resistance and low fracture risk, have the potential to extend the longevity of THA...

Cite
Mai K, Hardwick ME, Walker RH, et al. Early dislocation rate in ceramic-on-ceramic total hip arthroplasty. HSS J. 2008;4(1):10-3doi: 10.1007/s11420-007-9060-5.
Mai, K., Hardwick, M. E., Walker, R. H., Copp, S. N., Ezzet, K. A., & Colwell, C. W. (2008). Early dislocation rate in ceramic-on-ceramic total hip arthroplasty. HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 4(1), 10-3. https://doi.org/10.1007/s11420-007-9060-5
Mai, Kenny, et al. "Early dislocation rate in ceramic-on-ceramic total hip arthroplasty." HSS journal : the musculoskeletal journal of Hospital for Special Surgery vol. 4,1 (2008): 10-3. doi: https://doi.org/10.1007/s11420-007-9060-5
Mai K, Hardwick ME, Walker RH, Copp SN, Ezzet KA, Colwell CW. Early dislocation rate in ceramic-on-ceramic total hip arthroplasty. HSS J. 2008 Feb;4(1):10-3. doi: 10.1007/s11420-007-9060-5. PMID: 18751856; PMCID: PMC2504286.
Copy Download .nbib Format: NLM
Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomas.

Journal of neurological surgery. Part B, Skull base

Ivan ME, Cheng JS, Kaur G, Sughrue ME, Clark A, Kane AJ, Aranda D, McDermott M, Barani IJ, Parsa AT.
PMID: 23372999
J Neurol Surg B Skull Base. 2012 Feb;73(1):76-83. doi: 10.1055/s-0032-1304562.

Sphenoid wing meningiomas (SWMs) typically are histologically benign, insidious lesions, but the propensity of these tumors for local invasion makes disease control very challenging. In this review, we assess whether the degree of resection and extent of cavernous sinus...

Cite
Ivan ME, Cheng JS, Kaur G, et al. Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomas. J Neurol Surg B Skull Base. 2012;73(1):76-83doi: 10.1055/s-0032-1304562.
Ivan, M. E., Cheng, J. S., Kaur, G., Sughrue, M. E., Clark, A., Kane, A. J., Aranda, D., McDermott, M., Barani, I. J., & Parsa, A. T. (2012). Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomas. Journal of neurological surgery. Part B, Skull base, 73(1), 76-83. https://doi.org/10.1055/s-0032-1304562
Ivan, Michael E, et al. "Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomas." Journal of neurological surgery. Part B, Skull base vol. 73,1 (2012): 76-83. doi: https://doi.org/10.1055/s-0032-1304562
Ivan ME, Cheng JS, Kaur G, Sughrue ME, Clark A, Kane AJ, Aranda D, McDermott M, Barani IJ, Parsa AT. Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomas. J Neurol Surg B Skull Base. 2012 Feb;73(1):76-83. doi: 10.1055/s-0032-1304562. PMID: 23372999; PMCID: PMC3424017.
Copy Download .nbib Format: NLM
Corrigendum to "Protective effect of EX-527 against high-fat diet-induced diabetic nephropathy in Zucker rats" [Toxicology and Applied Pharmacology 390 (2020) 114899].

Toxicology and applied pharmacology

Kundu A, Richa S, Dey P, Kim KS, Son JY, Kim HR, Lee SY, Lee BH, Lee KY, Kacew S, Lee BM, Kim HS.
PMID: 32640284
Toxicol Appl Pharmacol. 2020 Sep 01;402:115128. doi: 10.1016/j.taap.2020.115128. Epub 2020 Jul 05.

No abstract available.

Cite
Kundu A, Richa S, Dey P, et al. Corrigendum to "Protective effect of EX-527 against high-fat diet-induced diabetic nephropathy in Zucker rats" [Toxicology and Applied Pharmacology 390 (2020) 114899]. Toxicol Appl Pharmacol. 2020;402:115128doi: 10.1016/j.taap.2020.115128.
Kundu, A., Richa, S., Dey, P., Kim, K. S., Son, J. Y., Kim, H. R., Lee, S. Y., Lee, B. H., Lee, K. Y., Kacew, S., Lee, B. M., & Kim, H. S. (2020). Corrigendum to "Protective effect of EX-527 against high-fat diet-induced diabetic nephropathy in Zucker rats" [Toxicology and Applied Pharmacology 390 (2020) 114899]. Toxicology and applied pharmacology, 402115128. https://doi.org/10.1016/j.taap.2020.115128
Kundu, Amit, et al. "Corrigendum to "Protective effect of EX-527 against high-fat diet-induced diabetic nephropathy in Zucker rats" [Toxicology and Applied Pharmacology 390 (2020) 114899]." Toxicology and applied pharmacology vol. 402 (2020): 115128. doi: https://doi.org/10.1016/j.taap.2020.115128
Kundu A, Richa S, Dey P, Kim KS, Son JY, Kim HR, Lee SY, Lee BH, Lee KY, Kacew S, Lee BM, Kim HS. Corrigendum to "Protective effect of EX-527 against high-fat diet-induced diabetic nephropathy in Zucker rats" [Toxicology and Applied Pharmacology 390 (2020) 114899]. Toxicol Appl Pharmacol. 2020 Sep 01;402:115128. doi: 10.1016/j.taap.2020.115128. Epub 2020 Jul 05. PMID: 32640284.
Copy Download .nbib Format: NLM
Management of Lower Extremity Pain from Chronic Venous Insufficiency: A Comprehensive Review.

Cardiology and therapy

Orhurhu V, Chu R, Xie K, Kamanyi GN, Salisu B, Salisu-Orhurhu M, Urits I, Kaye RJ, Hasoon J, Viswanath O, Kaye AJ, Karri J, Marshall Z, Kaye AD, Anahita D.
PMID: 33704678
Cardiol Ther. 2021 Jun;10(1):111-140. doi: 10.1007/s40119-021-00213-x. Epub 2021 Mar 11.

PURPOSE OF REVIEW: Chronic venous insufficiency is found to some extent in a large proportion of the world's population, especially in the elderly and obese. Despite its prevalence, little research has been pursued into this pathology when compared to...

Cite
Orhurhu V, Chu R, Xie K, et al. Management of Lower Extremity Pain from Chronic Venous Insufficiency: A Comprehensive Review. Cardiol Ther. 2021;10(1):111-140doi: 10.1007/s40119-021-00213-x.
Orhurhu, V., Chu, R., Xie, K., Kamanyi, G. N., Salisu, B., Salisu-Orhurhu, M., Urits, I., Kaye, R. J., Hasoon, J., Viswanath, O., Kaye, A. J., Karri, J., Marshall, Z., Kaye, A. D., & Anahita, D. (2021). Management of Lower Extremity Pain from Chronic Venous Insufficiency: A Comprehensive Review. Cardiology and therapy, 10(1), 111-140. https://doi.org/10.1007/s40119-021-00213-x
Orhurhu, Vwaire, et al. "Management of Lower Extremity Pain from Chronic Venous Insufficiency: A Comprehensive Review." Cardiology and therapy vol. 10,1 (2021): 111-140. doi: https://doi.org/10.1007/s40119-021-00213-x
Orhurhu V, Chu R, Xie K, Kamanyi GN, Salisu B, Salisu-Orhurhu M, Urits I, Kaye RJ, Hasoon J, Viswanath O, Kaye AJ, Karri J, Marshall Z, Kaye AD, Anahita D. Management of Lower Extremity Pain from Chronic Venous Insufficiency: A Comprehensive Review. Cardiol Ther. 2021 Jun;10(1):111-140. doi: 10.1007/s40119-021-00213-x. Epub 2021 Mar 11. PMID: 33704678; PMCID: PMC8126535.
Copy Download .nbib Format: NLM
Current opinion on risk assessment of cosmetics.

Journal of toxicology and environmental health. Part B, Critical reviews

Kim KB, Kwack SJ, Lee JY, Kacew S, Lee BM.
PMID: 33832410
J Toxicol Environ Health B Crit Rev. 2021 May 19;24(4):137-161. doi: 10.1080/10937404.2021.1907264. Epub 2021 Apr 08.

Risk assessment of cosmetic ingredients is a useful scientific method to characterize potential adverse effects resulting from using cosmetics. The process of risk assessment consists of four steps: hazard identification, dose-response assessment, exposure assessment, and risk characterization. Hazard identification...

Cite
Kim KB, Kwack SJ, Lee JY, et al. Current opinion on risk assessment of cosmetics. J Toxicol Environ Health B Crit Rev. 2021;24(4):137-161doi: 10.1080/10937404.2021.1907264.
Kim, K. B., Kwack, S. J., Lee, J. Y., Kacew, S., & Lee, B. M. (2021). Current opinion on risk assessment of cosmetics. Journal of toxicology and environmental health. Part B, Critical reviews, 24(4), 137-161. https://doi.org/10.1080/10937404.2021.1907264
Kim, Kyu-Bong, et al. "Current opinion on risk assessment of cosmetics." Journal of toxicology and environmental health. Part B, Critical reviews vol. 24,4 (2021): 137-161. doi: https://doi.org/10.1080/10937404.2021.1907264
Kim KB, Kwack SJ, Lee JY, Kacew S, Lee BM. Current opinion on risk assessment of cosmetics. J Toxicol Environ Health B Crit Rev. 2021 May 19;24(4):137-161. doi: 10.1080/10937404.2021.1907264. Epub 2021 Apr 08. PMID: 33832410.
Copy Download .nbib Format: NLM
Peripheral Nerve Stimulation: A Review of Techniques and Clinical Efficacy.

Pain and therapy

Kaye AD, Ridgell S, Alpaugh ES, Mouhaffel A, Kaye AJ, Cornett EM, Chami AA, Shah R, Dixon BM, Viswanath O, Urits I, Edinoff AN, Urman RD.
PMID: 34331668
Pain Ther. 2021 Dec;10(2):961-972. doi: 10.1007/s40122-021-00298-1. Epub 2021 Jul 31.

Chronic pain is a common source of morbidity in many patient populations worldwide. There are growing concerns about the potential side effects of currently prescribed medications and a continued need for effective treatment. Related to these concerns, peripheral nerve...

Cite
Kaye AD, Ridgell S, Alpaugh ES, et al. Peripheral Nerve Stimulation: A Review of Techniques and Clinical Efficacy. Pain Ther. 2021;10(2):961-972doi: 10.1007/s40122-021-00298-1.
Kaye, A. D., Ridgell, S., Alpaugh, E. S., Mouhaffel, A., Kaye, A. J., Cornett, E. M., Chami, A. A., Shah, R., Dixon, B. M., Viswanath, O., Urits, I., Edinoff, A. N., & Urman, R. D. (2021). Peripheral Nerve Stimulation: A Review of Techniques and Clinical Efficacy. Pain and therapy, 10(2), 961-972. https://doi.org/10.1007/s40122-021-00298-1
Kaye, Alan D, et al. "Peripheral Nerve Stimulation: A Review of Techniques and Clinical Efficacy." Pain and therapy vol. 10,2 (2021): 961-972. doi: https://doi.org/10.1007/s40122-021-00298-1
Kaye AD, Ridgell S, Alpaugh ES, Mouhaffel A, Kaye AJ, Cornett EM, Chami AA, Shah R, Dixon BM, Viswanath O, Urits I, Edinoff AN, Urman RD. Peripheral Nerve Stimulation: A Review of Techniques and Clinical Efficacy. Pain Ther. 2021 Dec;10(2):961-972. doi: 10.1007/s40122-021-00298-1. Epub 2021 Jul 31. PMID: 34331668; PMCID: PMC8586305.
Copy Download .nbib Format: NLM
Combination therapy patents: a new front in evergreening.

Nature biotechnology

Strohbehn GW, Kacew AJ, Goldstein DA, Feldman RC, Ratain MJ.
PMID: 34880460
Nat Biotechnol. 2021 Dec 08; doi: 10.1038/s41587-021-01137-6. Epub 2021 Dec 08.

No abstract available.

Cite
Strohbehn GW, Kacew AJ, Goldstein DA, et al. Combination therapy patents: a new front in evergreening. Nat Biotechnol. 2021;doi: 10.1038/s41587-021-01137-6.
Strohbehn, G. W., Kacew, A. J., Goldstein, D. A., Feldman, R. C., & Ratain, M. J. (2021). Combination therapy patents: a new front in evergreening. Nature biotechnology, . https://doi.org/10.1038/s41587-021-01137-6
Strohbehn, Garth W, et al. "Combination therapy patents: a new front in evergreening." Nature biotechnology vol. (2021). doi: https://doi.org/10.1038/s41587-021-01137-6
Strohbehn GW, Kacew AJ, Goldstein DA, Feldman RC, Ratain MJ. Combination therapy patents: a new front in evergreening. Nat Biotechnol. 2021 Dec 08; doi: 10.1038/s41587-021-01137-6. Epub 2021 Dec 08. PMID: 34880460.
Copy Download .nbib Format: NLM
Antimicrobial Resistance Profiles of Human Commensal .

Antibiotics (Basel, Switzerland)

Goytia M, Thompson ST, Jordan SVL, King KA.
PMID: 34066576
Antibiotics (Basel). 2021 May 06;10(5). doi: 10.3390/antibiotics10050538.

Pathogenic

Cite
Goytia M, Thompson ST, Jordan SVL, et al. Antimicrobial Resistance Profiles of Human Commensal . Antibiotics (Basel). 2021;10(5)doi: 10.3390/antibiotics10050538.
Goytia, M., Thompson, S. T., Jordan, S. V. L., & King, K. A. (2021). Antimicrobial Resistance Profiles of Human Commensal . Antibiotics (Basel, Switzerland), 10(5), . https://doi.org/10.3390/antibiotics10050538
Goytia, Maira, et al. "Antimicrobial Resistance Profiles of Human Commensal ." Antibiotics (Basel, Switzerland) vol. 10,5 (2021). doi: https://doi.org/10.3390/antibiotics10050538
Goytia M, Thompson ST, Jordan SVL, King KA. Antimicrobial Resistance Profiles of Human Commensal . Antibiotics (Basel). 2021 May 06;10(5). doi: 10.3390/antibiotics10050538. PMID: 34066576; PMCID: PMC8148603.
Copy Download .nbib Format: NLM
Spontaneous bladder diverticulum rupture due to a squamous cell carcinoma of the bladder: a case report.

Journal of surgical case reports

Sahnoun W, Ben Rhouma S, Kacem A, Mrad Dali K, Rekik I, Chelly B, Messaoudi Y, Ouanes Y, Sellami A, Nouira Y.
PMID: 33294156
J Surg Case Rep. 2020 Nov 28;2020(11):rjaa454. doi: 10.1093/jscr/rjaa454. eCollection 2020 Nov.

While bladder rupture is most of the time secondary to external injury such as trauma or iatrogenic events, spontaneous bladder rupture (SBR) is a rare condition which is mostly associated with bladder cancer, neurologic bladder or radiotherapy. We report...

Cite
Sahnoun W, Ben Rhouma S, Kacem A, et al. Spontaneous bladder diverticulum rupture due to a squamous cell carcinoma of the bladder: a case report. J Surg Case Rep. 2020;2020(11):rjaa454doi: 10.1093/jscr/rjaa454.
Sahnoun, W., Ben Rhouma, S., Kacem, A., Mrad Dali, K., Rekik, I., Chelly, B., Messaoudi, Y., Ouanes, Y., Sellami, A., & Nouira, Y. (2020). Spontaneous bladder diverticulum rupture due to a squamous cell carcinoma of the bladder: a case report. Journal of surgical case reports, 2020(11), rjaa454. https://doi.org/10.1093/jscr/rjaa454
Sahnoun, Wajih, et al. "Spontaneous bladder diverticulum rupture due to a squamous cell carcinoma of the bladder: a case report." Journal of surgical case reports vol. 2020,11 (2020): rjaa454. doi: https://doi.org/10.1093/jscr/rjaa454
Sahnoun W, Ben Rhouma S, Kacem A, Mrad Dali K, Rekik I, Chelly B, Messaoudi Y, Ouanes Y, Sellami A, Nouira Y. Spontaneous bladder diverticulum rupture due to a squamous cell carcinoma of the bladder: a case report. J Surg Case Rep. 2020 Nov 28;2020(11):rjaa454. doi: 10.1093/jscr/rjaa454. eCollection 2020 Nov. PMID: 33294156; PMCID: PMC7700774.
Copy Download .nbib Format: NLM
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Hengstler J, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP.
PMID: 32360905
Food Chem Toxicol. 2020 Aug;142:111349. doi: 10.1016/j.fct.2020.111349. Epub 2020 Apr 30.

Theoretically, both synthetic endocrine disrupting chemicals (S-EDCs) and natural (exogenous and endogenous) endocrine disrupting chemicals (N-EDCs) can interact with endocrine receptors and disturb hormonal balance. However, compared to endogenous hormones, S-EDCs are only weak partial agonists with receptor affinities...

Cite
Autrup H, Barile FA, Berry SC, et al. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?. Food Chem Toxicol. 2020;142:111349doi: 10.1016/j.fct.2020.111349.
Autrup, H., Barile, F. A., Berry, S. C., Blaauboer, B. J., Boobis, A., Bolt, H., Hengstler, J., Borgert, C. J., Dekant, W., Dietrich, D., Domingo, J. L., Gori, G. B., Greim, H., Kacew, S., Marquardt, H., Pelkonen, O., Savolainen, K., Heslop-Harrison, P., & Vermeulen, N. P. (2020). Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 142111349. https://doi.org/10.1016/j.fct.2020.111349
Autrup, Herman, et al. "Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?." Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association vol. 142 (2020): 111349. doi: https://doi.org/10.1016/j.fct.2020.111349
Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Hengstler J, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?. Food Chem Toxicol. 2020 Aug;142:111349. doi: 10.1016/j.fct.2020.111349. Epub 2020 Apr 30. PMID: 32360905.
Copy Download .nbib Format: NLM
Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology.

Toxicology letters

Barile FA, Berry SC, Blaauboer B, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Tsatsakis A, Vermeulen NP.
PMID: 33412252
Toxicol Lett. 2021 Apr 01;340:1-3. doi: 10.1016/j.toxlet.2020.12.020. Epub 2021 Jan 04.

No abstract available.

Cite
Barile FA, Berry SC, Blaauboer B, et al. Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology. Toxicol Lett. 2021;340:1-3doi: 10.1016/j.toxlet.2020.12.020.
Barile, F. A., Berry, S. C., Blaauboer, B., Boobis, A., Bolt, H., Borgert, C. J., Dekant, W., Dietrich, D., Domingo, J. L., Gori, G. B., Greim, H., Hengstler, J., Kacew, S., Marquardt, H., Pelkonen, O., Savolainen, K., Heslop-Harrison, P., Tsatsakis, A., & Vermeulen, N. P. (2021). Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology. Toxicology letters, 3401-3. https://doi.org/10.1016/j.toxlet.2020.12.020
Barile, Frank A, et al. "Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology." Toxicology letters vol. 340 (2021): 1-3. doi: https://doi.org/10.1016/j.toxlet.2020.12.020
Barile FA, Berry SC, Blaauboer B, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Tsatsakis A, Vermeulen NP. Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology. Toxicol Lett. 2021 Apr 01;340:1-3. doi: 10.1016/j.toxlet.2020.12.020. Epub 2021 Jan 04. PMID: 33412252.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 92 entries